Results 221 to 230 of about 312,365 (256)

Development of a rapid tool for screening financial toxicity based on the comprehensive score for financial toxicity

Journal of Cancer Policy
This study aimed to use item response theory (IRT) to develop and validate a short version of the Chinese COmprehensive Score for financial Toxicity (COST-S-C) in patients with cancer.A total of 500 patients with cancer participated in the survey. Confirmatory factor analysis (CFA) was used to assess the factor structure of the COST-S-C.
Ling-Ling, Wang, Richard Huan, Xu
openaire   +2 more sources

Financial Toxicity of Cancer Treatment

JAMA Oncology, 2022
S M Qasim, Hussaini, Arjun, Gupta, Stacie B, Dusetzina   +2 more
openaire   +2 more sources

Objective predictors of financial toxicity in oncology

The American Journal of Managed Care
Current financial toxicity (FT) screening tools rely on patient-reported risk factors. Underrepresented populations may not be forthcoming about FT fears due to cultural concerns of treatment withholding or migratory repercussions, if applicable. Identifying objective risk factors, such as social determinants of health (SDOH) and disease-specific ...
Aleksei, Bazhenov, Luiza, Doro, David M, O'Sullivan, Alvaro, Menendez   +3 more
openaire   +2 more sources

Financial Toxicity in Patients With Chronic Pancreatitis

Pancreas
Objectives Patients with chronic illnesses are susceptible to the financial burden of disease-related treatment costs. Financial toxicity is well researched in cancer and several chronic diseases. This review explores the financial challenges faced by patients with chronic pancreatitis and the impact of financial hardship on ...
Radmila Choate, Carrigan Wasilchenko, Kshitij Thakur, Rachel Hill, Elizabeth Wright, Darwin L. Conwell   +5 more
openaire   +2 more sources

Let’s Talk About Financial Toxicities

Oncology Nursing Forum, 2018
I have attended a number of conferences in the past few months that have included excellent sessions about precision medicine, targeted therapies, and personalized medicine. there terms may be confusing, and the generic names of the various drugs, not to mention the trade names, present some unique challenges.
openaire   +2 more sources

Financial Toxicity

The National Catholic Bioethics Quarterly, 2018
Pricivel Carrera, S. Yousuf Zafar
openaire   +2 more sources

Financial Toxicity in Surgery

Annals of Surgery, 2022
Karan R, Chhabra, Thomas C, Tsai
openaire   +2 more sources

Financial Toxicity

Forum, 2023
openaire   +1 more source

Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma

Clinical Lymphoma Myeloma and Leukemia
Patients with multiple myeloma (MM) may be on therapy for years, which can lead to financial toxicity (FinTox) or time toxicity (TimeTox). The prevalence, predictors, and quality of life (QOL) impacts of FinTox and TimeTox during different phases of MM treatment have not been characterized.We conducted a single-center cross-sectional survey of patients
Rahul Banerjee, Andrew J. Cowan, Marivel Ortega, Constance Missimer, Paul A. Carpenter, Masumi Ueda Oshima, Rachel B. Salit, Phuong T. Vo, Catherine J. Lee, Rohtesh S. Mehta, Nicole M. Kuderer, Veena Shankaran, Stephanie J. Lee, Christopher T. Su   +13 more
openaire   +2 more sources

Navigating financial toxicity in patients with cancer: A multidisciplinary management approach

Ca-A Cancer Journal for Clinicians, 2022
Maria Pisu, Grace Smith, Matthew Banegas   +2 more
exaly